Addition of Fluorine and a Late-Stage Functionalization (LSF) of the Oral SERD AZD9833 | ACS Medicinal Chemistry Letters
Discovery and Development of Cyclic Peptide Inhibitors of CIB1 | ACS Medicinal Chemistry Letters
Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1) | ACS Medicinal Chemistry Letters
Design, Synthesis, and Anti-HBV Activity of New Bis(l-amino acid) Ester Tenofovir Prodrugs | ACS Medicinal Chemistry Letters
Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35 | ACS Medicinal Chemistry Letters
Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors | ACS Medicinal Chemistry Letters
GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family | ACS Medicinal Chemistry Letters
Structural and Functional Characterization of Indane-Core CD4-Mimetic Compounds Substituted with Heterocyclic Amines | ACS Medicinal Chemistry Letters
Readily Accessible High-Throughput Experimentation: A General Protocol for the Preparation of ChemBeads and EnzyBeads | ACS Medicinal Chemistry Letters
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design | ACS Medicinal Chemistry Letters
Massively Parallel Optimization of the Linker Domain in Small Molecule Dimers Targeting a Toxic r(CUG) Repeat Expansion | ACS Medicinal Chemistry Letters
Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents | ACS Medicinal Chemistry Letters
Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C | ACS Medicinal Chemistry Letters
Artificial Intelligence in Drug Design—The Storm Before the Calm? | ACS Medicinal Chemistry Letters
Identification of New Small-Molecule Inducers of Estrogen-related Receptor α (ERRα) Degradation | ACS Medicinal Chemistry Letters